Francis E. O’Donnell, Jr., M.D.

Special Advisor

Dr O’Donnell is our chief medical officer. As such he is part of the team that is responsible for strategy, direction, and execution of the Company’s clinical development plans.  In addition, he works with senior management to evaluate the scientific, and clinical viability of potential products, assessing their commercial potential to address unmet medical indications taking into account approved drugs as well as drugs under development by competitors. Dr. O’Donnell has thirty years of experience in pharmaceutical development. 

He received his BA from Johns Hopkins University’s accelerated program and his MD from Johns Hopkins University School of Medicine, as well as his specialty and fellowship training. He is an inventor or co-inventor on over 40 US patents.